Kurosawa S, Shimomura Y, Itonaga H, Najima Y, et al. Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis. Bone Marrow Transplant 2021;56:3008-3015.
PMID: 34489555